XASX
TD1
Market cap2mUSD
Oct 30, Last price
0.08AUD
1D
0.00%
1Q
-7.41%
Jan 2017
-96.61%
IPO
-99.97%
Name
Tali Digital Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
TALi Digital Limited is an Australian digital health firm dedicated to improving cognitive function and behavior through its diagnostic and therapeutic offerings. The company provides TALi DETECT, an evidence-based digital screening program lasting 20-30 minutes, which utilizes cognitive assessments to gauge a child's attention skills relative to their peers. Complementing this is TALi TRAIN, a digital cognitive training solution designed to enhance selective attention and numeracy, and in certain cases, alleviate inattentive and hyperactive behaviors in children. The company maintains a significant licensing agreement with Akili Interactive Labs, Inc. for pediatric cognitive products. Founded in 2004, the enterprise, headquartered in Camberwell, was formerly known as Novita Healthcare Limited until its name change in December 2019.
Key people
Chairman of the Board · since 2022
Mary Brinson
Interim Chief Executive Officer, Chief Medical Officer · since 2022
Tim Luscombe
Company Secretary · since 2022
Non-Executive Director · since 2020
Additional Non-Executive Director · since 2022
Headquarters & legal address
Level 5, 19 William Street
Cremorne, VIC 3121
AU
Cremorne, VIC 3121
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||